Igc pharma announces publication of ims spotlight interview highlighting strategic expansion in alzheimer's and weight loss therapies

Potomac, md / accesswire / november 6, 2024 / igc pharma, inc. (nyse american:igc) ("igc pharma" or the "company") is pleased to announce the publication of a new interview with ceo ram mukunda, now available as part of the ims spotlight series. in the interview, ram mukunda discusses igc's strategic expansion into metabolic and neurological markets, specifically addressing the potential of glp-1 agonists in both alzheimer's and weight loss therapies.
IGC Ratings Summary
IGC Quant Ranking